SCHEMBL14895109

SCHEMBL14895109

CCc1cnc2c(N3CCC(N(C)C(=O)O)C3)nc(N)nc2c1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 12/20 0.63
▸ HRH3 Q9Y5N1 12/20 0.63
▸ KCNH2 Q12809 7/20 0.63
▸ HRH1 P35367 4/20 0.63
▸ HRH2 P25021 3/20 0.63
▸ MAP4K4 O95819 1/20 0.39
▸ JAK2 O60674 1/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ OPRD1 P41143 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ OGFRL1 Q5TC84 1/20 0.38
▸ PIK3CD O00329 3/20 0.36
▸ PIK3CA P42336 3/20 0.36
▸ PIK3CB P42338 3/20 0.36
▸ PIK3CG P48736 3/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14895429 0.92 HRH3 (0.64) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14907373 0.87 HRH4 (0.58) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895282 0.84 HRH4 (0.59) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14907370 0.79 HRH3 (0.57) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895169 0.78 HRH4 (0.64) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895496 0.78 HRH4 (1.00) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895370 0.78 HRH4 (0.44) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895497 0.78 HRH4 (1.00) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895240 0.77 HRH4 (0.65) HRH4HRH3KCNH2HRH1HRH2
SCHEMBL14895452 0.76 PRKDC (0.41) HRH4HRH3MAP4K4JAK2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013060881-A1 PYRIDOPYRIMIDINES AND THEIR THERAPEUTIC USE VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG (NL) 2013-05-02 — — WO disclosed
Send feedback